Trial Profile
A Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled Study of the Safety ' Efficacy of HTU-520 in the Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Jun 2015
Price :
$35
*
At a glance
- Drugs Terbinafine (Primary)
- Indications Onychomycosis
- Focus Therapeutic Use
- Sponsors Hisamitsu Pharmaceutical
- 02 May 2014 New trial record